CANSF - Willow Biosciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.3305
-0.0644 (-16.30%)
At close: 12:11PM EDT
Stock chart is not supported by your current browser
Previous Close0.3949
Open0.3646
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3305 - 0.3789
52 Week Range0.2400 - 2.1775
Volume4,000
Avg. Volume8,793
Market Cap25.663M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Willow Biosciences Reports Fourth Quarter and 2019 Year End Results and Operational Update
    PR Newswire

    Willow Biosciences Reports Fourth Quarter and 2019 Year End Results and Operational Update

    Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF) is pleased to announce its financial and operating results for the three months and year ended December 31, 2019. Selected financial and operational information is outlined below and should be read with Willow's audited consolidated financial statements (the "Financial Statements") and management's discussion and analysis (the "MD&A;") as of December 31, 2019, which are available on SEDAR at www.sedar.com and on Willow's website at www.willowbio.com. The Company's annual information form (the "AIF") for the year ended December 31, 2019 has also been filed on SEDAR and is available on Willow's website.

  • InvestmentPitch Media Video Discusses Willow Biosciences' Cannabinoid Scale-Up and Expedited Path to Commercialization - Video Available on Investmentpitch.com
    Newsfile

    InvestmentPitch Media Video Discusses Willow Biosciences' Cannabinoid Scale-Up and Expedited Path to Commercialization - Video Available on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - March 13, 2020) - Willow Biosciences (TSX: WLLW) (OTCQB: CANSF) has achieved its first major commercial milestone by delivering a proprietary cannabinoid-producing yeast strain to its scale-up development partner, Albany Molecular Research, Inc. ("AMRI") to begin the process of scaling up production to commercial volumes. AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life.For ...

  • Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization
    PR Newswire

    Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization

    Willow Biosciences Inc. ("Willow" or "the Company") (TSX: WLLW; OTCQB: CANSF), is pleased to announce that it has achieved its first major commercial milestone by delivering a proprietary cannabinoid-producing yeast strain to its scale-up development partner, Albany Molecular Research, Inc. ("AMRI") to begin the process of scaling up production to commercial volumes.

  • Willow Biosciences Improves Governance with Appointment of Independent Chairman
    PR Newswire

    Willow Biosciences Improves Governance with Appointment of Independent Chairman

    Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF) is pleased to announce that it has appointed Dr. Peter Seufer-Wasserthal as independent Chairman of the Board of Directors and Dr. Joseph Tucker as Chief Operating Officer of Willow.

  • Willow Biosciences Announces Trading Date on the Toronto Stock Exchange
    PR Newswire

    Willow Biosciences Announces Trading Date on the Toronto Stock Exchange

    Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received final approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the TSX.

  • Willow Biosciences Comments on Descheduling of Partner's Cannabidiol by U.S. Drug Enforcement Agency
    PR Newswire

    Willow Biosciences Comments on Descheduling of Partner's Cannabidiol by U.S. Drug Enforcement Agency

    Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced cannabidiol ("CBD"), comments on Purisys, LLC's ("Purisys") news release issued on November 21st stating that the U.S. Drug Enforcement Agency (the "DEA") has removed Purisys' CBD from Schedule I of the Controlled Substances Act (the "CSA"). Purisys is the spin-out entity of Noramco, Inc.'s ("Noramco") industry-leading cannabinoids business, which began to operate as a stand-alone entity from Noramco on October 1st, 2019 and is expected to become independent from Noramco on January 1st, 2020. Noramco is Willow's exclusive manufacturing and distribution partner as per the terms of the Joint Development Agreement between Willow and Noramco announced on June 4, 2019, and Willow maintains an informal partnership with Purisys through the Joint Development Agreement (collectively, the "Partnership").

  • InvestmentPitch Media Video Discusses Willow Biosciences and its Conditional Approval from the Toronto Stock Exchange to List its Shares on the TSX - Video Available on Investmentpitch.com
    Newsfile

    InvestmentPitch Media Video Discusses Willow Biosciences and its Conditional Approval from the Toronto Stock Exchange to List its Shares on the TSX - Video Available on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - November 26, 2019) - Willow Biosciences (CSE: WLLW) has received conditional approval from the Toronto Stock Exchange to list its common shares on the TSX. Upon listing, the company will voluntarily delist from the Canadian Securities Exchange.Trevor Peters, President and CEO, stated: "Listing on the TSX is a significant milestone for Willow. The TSX will broaden our investment appeal and leave us well positioned to execute on our strategic ...

  • Willow Biosciences Receives Conditional Approval to List on the Toronto Stock Exchange
    CNW Group

    Willow Biosciences Receives Conditional Approval to List on the Toronto Stock Exchange

    CALGARY , Nov. 25, 2019 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the TSX. "Listing on the TSX is a significant milestone for Willow," said Trevor Peters , President and Chief Executive Officer of the Company.

  • Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update
    CNW Group

    Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update

    CALGARY , Nov. 21, 2019 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW, OTCQB: CANSF) has released its financial and operating results for the three and nine months ended September 30, 2019 . "Over the past few months, Willow has continued to advance its business strategy and achieved several important milestones," said Trevor Peters , Willow's President and Chief Executive Officer. Selected financial and operational information is outlined below and should be read in conjunction with Willow's unaudited condensed consolidated interim financial statements ("Financial Statements") and related management's discussion and analysis ("MD&A") which are available on SEDAR at www.sedar.com or on the Willow's website at www.willowbio.com.

  • Willow Biosciences to Participate in Cowen 2nd Annual Boston Cannabis Conference
    CNW Group

    Willow Biosciences to Participate in Cowen 2nd Annual Boston Cannabis Conference

    CALGARY , Nov. 7, 2019 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it will participate in the Cowen 2nd Annual Boston Cannabis Conference being held on November 12th and 13th, 2019, at the InterContinental Boston. Dr. Chris Savile , Vice President, Commercial Operations of the Company, will be speaking on a Biosynthesis panel on November 13 th at 8:50am EST . Chris Savile and Travis Doupe, Chief Financial Officer of the Company, will be available for meetings throughout the conference, which can be arranged through Cowen's one-on-one meeting system.

  • Benzinga

    Willow Biosciences To Trade On The OTCQB Venture Market

    The company said the listing on the U.S. market will enable it to reach a wider base of retail and institutional investors, and make it more transparent and liquid. Willow Biosciences is a Canadian-based biotechnology company with the main focus on the production of cannabinoids.

  • PR Newswire

    Willow Biosciences to Commence Trading on the OTCQB® Venture Market

    CALGARY, Nov. 5, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE:WLLW; OTCQB:CANSF) is pleased to announce that it has been approved to commence trading on The OTCQB® Venture Market (the "OTCQB"), beginning today, November 5, 2019, under the symbol "CANSF". This U.S. listing will provide the Company with access to a broader base of U.S. and international retail and institutional investors, ultimately providing investors with increased access to data, transparency and liquidity. Quotes for Willow's U.S. symbol will be available once the Company's stock commences trading today on the OTCQB at www.otcmarkets.com/stock/CANSF/quote.

  • Synthetic Cannabinoids: The New Age of Medical Marijuana-- CFN Media
    Newsfile

    Synthetic Cannabinoids: The New Age of Medical Marijuana-- CFN Media

    Seattle, Washington--(Newsfile Corp. - July 22, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Willow Biosciences (CSE: WLLW) (OTC: CANSF) and the fascinating world of biosynthetically produced cannabinoids.Believe it or not, the world's first blockbuster drug is still one of the most commonly used today. Acetylsalicylic acid, better known as Aspirin®, is a synthetic ...

  • Makena Resources Corporate Update
    Newsfile

    Makena Resources Corporate Update

    Vancouver, British Columbia--(Newsfile Corp. - September 20, 2018) - Makena Resources Inc. (CSE: MKNA) (OTC: CANSF) (the "Company" or "Makena") is pleased to announce that it is actively evaluating additional corporate growth drivers in sectors other than mining, including the life sciences sector. At this time, no new project has been contemplated, and there is no guarantee that one will be acceptable and/or approved by the board.Makena has fulfilled all of its obligations in ...

  • Makena Grants Stock Options
    Newsfile

    Makena Grants Stock Options

    Vancouver, British Columbia--(Newsfile Corp. - September 14, 2018) - Makena Resources Inc. (CSE: MKNA) (the "Company" or "Makena") has granted 500,000 stock options at an exercise price of $0.15 to directors of the Company for a term of one year, pursuant to its Rolling Stock Option Plan.If you would like to be added to Makena's news distribution list please send your email address to info@makenaresources.com About Makena Resources Makena Resources is a Canadian-based ...

  • Makena Provides Corporate Update
    Newsfile

    Makena Provides Corporate Update

    Vancouver, British Columbia--(Newsfile Corp. - September 13, 2018) - Makena Resources Inc. (CSE: MKNA) (the "Company" or "Makena") announces that, the Company continues to perform due diligence on the property located in close proximity to the Forrest Kerr Gold property under exploration by Aben Resources Ltd, as previously announced on August 10 , 2018.In other news, the Company anticipates closing on or about September 19, 2018 on its previously announced Moosehead North Gold ...

  • Makena Resources Quadruples Land Position in Emerging Moosehead Gold District
    Newsfile

    Makena Resources Quadruples Land Position in Emerging Moosehead Gold District

    Vancouver, British Columbia--(Newsfile Corp. - August 14, 2018) - Makena Resources Inc. (the "Company" or "Makena") is pleased to announce that it has agreed to acquire a significant mineral tenure position in the emerging Moosehead Gold District located in Newfoundland, Canada, consisting of 73 mineral claims (the "Property")."Makena is excited to significantly expand our gold exploration project in the Moosehead Gold District. Our recently announced exploration plans for this developing gold camp will benefit ...

  • Makena Resources in Due Diligence Phase on Prospective Property in B.C.'s Golden Triangle
    Newsfile

    Makena Resources in Due Diligence Phase on Prospective Property in B.C.'s Golden Triangle

    Vancouver, British Columbia--(Newsfile Corp. - August 10, 2018) - Makena Resources Inc. (CSE: MKNA) (FSE: 45CN) (OTC: CANSF) (the "Company" or "Makena") is pleased to announce that it has entered into a 30-day due diligence period for a Property ("the Property") located close to the Forrest Kerr Gold property under exploration by Aben Resources Ltd. ("Aben").The Property covers 3,028 hectares of felsic intrusive located 1.1km west of the Forrest Kerr Gold property and approximately ...

  • Makena Resources to Explore Its Moosehead Northeast Gold Claims in Newfoundland
    Newsfile

    Makena Resources to Explore Its Moosehead Northeast Gold Claims in Newfoundland

    Vancouver, British Columbia--(Newsfile Corp. - August 9, 2018) - Makena Resources Inc. (CSE: MKNA) (FSE: 45CN) (OTC: CANSF) (the "Company" or "Makena") is pleased to announce that it is currently planning an exploration work on it's recently purchased Moosehead Northeast property ("Property") located in the vicinity of Sokoman Iron Corp. ("Sokoman") and their recent discovery hole at their Moosehead Gold project in Central Newfoundland.The first phase of work includes a review of the Newfoundland ...

  • Makena Resources Acquires Moosehead North Gold Claims in Newfoundland
    Newsfile

    Makena Resources Acquires Moosehead North Gold Claims in Newfoundland

    Vancouver, British Columbia--(Newsfile Corp. - August 8, 2018) - Makena Resources Inc. (CSE: MKNA) (the "Company" or "Makena") is pleased to announce that it has purchased a 100% interest in the Moosehead Northeast claims in the vicinity of Sokoman Iron Corp. ("Sokoman") and their recent discovery hole at their Moosehead Gold project in Central Newfoundland.The 600-hectare Property is made of 25 claims and is located 3.5 kilometers ("km") east from the eastern boundary of ...